Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
3976
DELISTED
Radius Recycling
RDUS
| $3.88M | ﹤0.01% |
139,480
-138,506
| -50% | -$4.28M |
|
|
SCPL
3977
PUT
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $3.88M | ﹤0.01% |
170,500
-900
| -0.5% | -$19.3K |
|
3978
CALL
Papa John's
PZZA
$799M
| $3.88M | ﹤0.01% |
56,900
+14,900
| +35% | +$1.15M |
|
3979
CALL
Teledyne Technologies
TDY
$31.5B
| $3.88M | ﹤0.01% |
9,500
+6,500
| +217% | +$2.64M |
|
3980
Qualys
QLYS
$6.44B
| $3.88M | ﹤0.01% |
25,406
-443
| -2% | -$63.7K |
|
3981
CALL
BioCryst Pharmaceuticals
BCRX
$2.49B
| $3.87M | ﹤0.01% |
547,300
-55,800
| -9% | -$401K |
|
|
VSXY
3982
PUT
Victoria's Secret
VSXY
$7.08B
| $3.87M | ﹤0.01% |
232,200
+97,000
| +72% | +$1.83M |
|
3983
CALL
Mattel
MAT
$4.29B
| $3.87M | ﹤0.01% |
175,600
+48,600
| +38% | +$1.04M |
|
3984
Larimar Therapeutics
LRMR
$453M
| $3.87M | ﹤0.01% |
979,186
-197,469
| -17% | -$747K |
|
3985
CALL
Brinker International
EAT
$10.2B
| $3.87M | ﹤0.01% |
122,400
+3,200
| +3% | +$112K |
|
3986
NeoGenomics
NEO
$2.05B
| $3.86M | ﹤0.01% |
313,572
-176,645
| -36% | -$2.63M |
|
|
AXON
3987
Axon Enterprise
AXON
$49.8B
| $3.86M | ﹤0.01% |
19,376
+7,388
| +62% | +$1.45M |
|
3988
PUT
Howmet Aerospace
HWM
$115B
| $3.85M | ﹤0.01% |
83,300
-14,300
| -15% | -$697K |
|
3989
CALL
Woodward
WWD
$21.9B
| $3.85M | ﹤0.01% |
31,000
+27,400
| +761% | +$3.42M |
|
3990
PUT
Guidewire Software
GWRE
$14.6B
| $3.85M | ﹤0.01% |
42,800
+10,400
| +32% | +$868K |
|
3991
PUT
Emcor
EME
$36.9B
| $3.85M | ﹤0.01% |
18,300
+14,900
| +438% | +$3.12M |
|
3992
PUT
Marqeta
MQ
$1.7B
| $3.85M | ﹤0.01% |
160,900
-220,725
| -58% | -$5.01M |
|
|
MRNS
3993
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.85M | ﹤0.01% |
478,009
+175,697
| +58% | +$1.46M |
|
3994
CALL
iShares S&P 500 Growth ETF
IVW
$77.6B
| $3.85M | ﹤0.01% |
56,200
-6,500
| -10% | -$460K |
|
3995
PUT
Oxford Industries
OXM
$543M
| $3.85M | ﹤0.01% |
40,000
+38,300
| +2,253% | +$3.89M |
|
3996
PUT
Leidos
LDOS
$18B
| $3.84M | ﹤0.01% |
41,700
+7,500
| +22% | +$706K |
|
3997
Innovator US Equity Accelerated ETF Quarterly
XDSQ
$78.2M
| $3.84M | ﹤0.01% |
139,204
+120,007
| +625% | +$3.45M |
|
3998
Genesco
GCO
$391M
| $3.84M | ﹤0.01% |
124,649
+96,036
| +336% | +$2.73M |
|
3999
JFrog
FROG
$11.6B
| $3.84M | ﹤0.01% |
151,447
-88,310
| -37% | -$2.45M |
|
4000
PUT
Impinj
PI
$5.28B
| $3.84M | ﹤0.01% |
69,700
+39,800
| +133% | +$2.7M |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.